Literature DB >> 35567624

How do endoscopic bladder tumor resection techniques affect pathology practice? EAU Section of Uro-Technology (ESUT) and Uropathology (ESUP) survey.

Selcuk Guven1, Maurizio Colecchia2, Pembe Oltulu3, Giulia Bonfante4, Dmitry Enikeev5, Hasan Esen3, Thomas Herrmann6, Lukas Lusuardi7, Salvatore Micali4, Bashkar Somani8, Andreas Skolarikos9, Alberto Breda10, Evangelos Liatsikos11, Joan Palou Redorta10, Ali Serdar Gozen12.   

Abstract

PURPOSE: We aimed to examine how different endoscopic bladder tumor resection techniques affect pathologists' clinical practice patterns.
METHODS: An online survey including 28 questions clustered in four main sections was prepared by the ESUT ERBT Working Group and released to the pathologists working in the institutions of experts of the ESUT Board and the working groups and experts in the uropathology working group. A descriptive analysis was performed using the collected data.
RESULTS: Sixty-eight pathologists from 23 countries responded to the survey. 37.3% of the participants stated that they always report the T1 sub-staging. Of those who gave sub-staging, 61.3% used T1a, b. 85.2% think that en bloc samples provide spatial orientation faster than piecemeal samples, and 60% think en bloc samples are timesaving during an inspection. 55.7% stated that whether the tissue sample is en bloc or piecemeal is essential. 57.4% think en bloc sample reduces turnaround time and is cost-effective for 44.1%. A large number of pathologists find that the pathology examination of piecemeal samples has a longer learning curve.
CONCLUSION: The survey shows that pathologists think that they can diagnose faster, accurately, and cost-effectively with ERBT samples, but they do not often encounter them in practice. Moreover, en bloc samples may be a better choice in pathology resident training. Evidence from real-life observational pathology practice and clinical research can reveal the current situation more clearly and increase awareness on proper treatment in endoscopic management of bladder tumors.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Bladder cancer; Cost; ERBT; En bloc resection; Laser; Pathology; TUR; Turnover time

Year:  2022        PMID: 35567624     DOI: 10.1007/s00345-022-04022-2

Source DB:  PubMed          Journal:  World J Urol        ISSN: 0724-4983            Impact factor:   4.226


  24 in total

1.  Small urothelial carcinoma: diagnosis and treatment by cold forceps biopsy.

Authors:  G Bianchi; P Novelli; P Beltrami; M Bonzanini; G Mobilio
Journal:  J Urol       Date:  1990-10       Impact factor: 7.450

2.  A new technique for transurethral resection of bladder tumors: rotational tumor resection using a new arched electrode.

Authors:  T Kawada; K Ebihara; T Suzuki; K Imai; H Yamanaka
Journal:  J Urol       Date:  1997-06       Impact factor: 7.450

3.  Transurethral resection in one piece (TURBO) is an accurate tool for pathological staging of bladder tumor.

Authors:  Rinzo Ukai; Kunihiro Hashimoto; Tsuguo Iwasa; Hirofumi Nakayama
Journal:  Int J Urol       Date:  2010-06-09       Impact factor: 3.369

Review 4.  Transurethral en bloc resection of nonmuscle invasive bladder cancer: trend or hype.

Authors:  Thomas R W Herrmann; Mathias Wolters; Mario W Kramer
Journal:  Curr Opin Urol       Date:  2017-03       Impact factor: 2.309

Review 5.  Challenges in the pathology of non-muscle-invasive bladder cancer: a dialogue between the urologic surgeon and the pathologist.

Authors:  Donna E Hansel; Jeremy S Miller; Michael S Cookson; Sam S Chang
Journal:  Urology       Date:  2013-03-19       Impact factor: 2.649

6.  Global Trends of Bladder Cancer Incidence and Mortality, and Their Associations with Tobacco Use and Gross Domestic Product Per Capita.

Authors:  Jeremy Yuen-Chun Teoh; Junjie Huang; Wendy Yuet-Kiu Ko; Veeleah Lok; Peter Choi; Chi-Fai Ng; Shomik Sengupta; Hugh Mostafid; Ashish M Kamat; Peter C Black; Shahrokh Shariat; Marek Babjuk; Martin Chi-Sang Wong
Journal:  Eur Urol       Date:  2020-09-21       Impact factor: 20.096

7.  Current Standards in the Endoscopic Management of Bladder Cancer: A Survey Evaluation among Urologists in German-Speaking Countries.

Authors:  Rodrigo Suarez-Ibarrola; Simon Hein; Erik Farin; Frank Waldbillig; Maximilian C Kriegmair; Manuel Ritter; Hans C Klingler; Thomas R W Herrmann; Christian Gratzke; Arkadiusz Miernik
Journal:  Urol Int       Date:  2020-03-25       Impact factor: 2.089

8.  EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer-An International Collaborative Multistakeholder Effort: Under the Auspices of the EAU-ESMO Guidelines Committees.

Authors:  J Alfred Witjes; Marek Babjuk; Joaquim Bellmunt; H Maxim Bruins; Theo M De Reijke; Maria De Santis; Silke Gillessen; Nicholas James; Steven Maclennan; Juan Palou; Tom Powles; Maria J Ribal; Shahrokh F Shariat; Theo Van Der Kwast; Evanguelos Xylinas; Neeraj Agarwal; Tom Arends; Aristotle Bamias; Alison Birtle; Peter C Black; Bernard H Bochner; Michel Bolla; Joost L Boormans; Alberto Bossi; Alberto Briganti; Iris Brummelhuis; Max Burger; Daniel Castellano; Richard Cathomas; Arturo Chiti; Ananya Choudhury; Eva Compérat; Simon Crabb; Stephane Culine; Berardino De Bari; Willem De Blok; Pieter J L De Visschere; Karel Decaestecker; Konstantinos Dimitropoulos; Jose L Dominguez-Escrig; Stefano Fanti; Valerie Fonteyne; Mark Frydenberg; Jurgen J Futterer; Georgios Gakis; Bogdan Geavlete; Paolo Gontero; Bernhard Grubmüller; Shaista Hafeez; Donna E Hansel; Arndt Hartmann; Dickon Hayne; Ann M Henry; Virginia Hernandez; Harry Herr; Ken Herrmann; Peter Hoskin; Jorge Huguet; Barbara A Jereczek-Fossa; Rob Jones; Ashish M Kamat; Vincent Khoo; Anne E Kiltie; Susanne Krege; Sylvain Ladoire; Pedro C Lara; Annemarie Leliveld; Estefania Linares-Espinós; Vibeke Løgager; Anja Lorch; Yohann Loriot; Richard Meijer; M Carmen Mir; Marco Moschini; Hugh Mostafid; Arndt-Christian Müller; Christoph R Müller; James N'Dow; Andrea Necchi; Yann Neuzillet; Jorg R Oddens; Jan Oldenburg; Susanne Osanto; Wim J G Oyen; Luís Pacheco-Figueiredo; Helle Pappot; Manish I Patel; Bradley R Pieters; Karin Plass; Mesut Remzi; Margitta Retz; Jonathan Richenberg; Michael Rink; Florian Roghmann; Jonathan E Rosenberg; Morgan Rouprêt; Olivier Rouvière; Carl Salembier; Antti Salminen; Paul Sargos; Shomik Sengupta; Amir Sherif; Robert J Smeenk; Anita Smits; Arnulf Stenzl; George N Thalmann; Bertrand Tombal; Baris Turkbey; Susanne Vahr Lauridsen; Riccardo Valdagni; Antoine G Van Der Heijden; Hein Van Poppel; Mihai D Vartolomei; Erik Veskimäe; Antoni Vilaseca; Franklin A Vives Rivera; Thomas Wiegel; Peter Wiklund; Andrew Williams; Richard Zigeuner; Alan Horwich
Journal:  Eur Urol       Date:  2019-11-19       Impact factor: 20.096

Review 9.  A contemporary update on pathology standards for bladder cancer: transurethral resection and radical cystectomy specimens.

Authors:  Donna E Hansel; Mahul B Amin; Eva Comperat; Richard J Cote; Ruth Knüchel; Rodolfo Montironi; Victor E Reuter; Mark S Soloway; Saleem A Umar; Theodorus H Van der Kwast
Journal:  Eur Urol       Date:  2012-10-12       Impact factor: 20.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.